Table 2.
Age Group | No. of Doses of HPV Vaccine Received |
Vaccination Coverage, % |
|
---|---|---|---|
Male | Female | ||
11–12 y | ≥1 | 16.4 | 27.1 |
≥2 | 7.2 | 14.9 | |
3 | 2.4 | 6.5 | |
13–15 y | ≥1 | 20.7 | 47.9 |
≥2 | 11.3 | 36.5 | |
3 | 5.2 | 25.2 | |
16–18 y | ≥1 | 18.0 | 57.1 |
≥2 | 9.8 | 47.6 | |
3 | 4.6 | 37.4 | |
11–12 y | 3-dose series completion* | 13.5 | 22.9 |
13–15 y | 3-dose series completion* | 23.2 | 52.2 |
16–18 y | 3-dose series completion* | 24.7 | 65.5 |
HPV = human papillomavirus.
Percentage of male and female adolescents who received 3 doses among those who had at least 1 HPV dose as of quarter 4, 2012, regardless of time elapsed between first HPV vaccination and end of quarter.